Pharmafile Logo
Pharmafocus logo
Advanced Search

EMA recommend new treatment option for severe postpartum haemorrhage

April 25, 2022
Sales and Marketing

Novo Nordisk has announced that the EMA Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion …

News

Ukraine: crisis for people with chronic diseases

April 25, 2022
Sales and Marketing

Preliminary results from an ongoing nationwide health needs assessment, conducted by WHO in partnership with Premise, indicate that one in …

News

Vivesto signs agreement with CRO to evaluate anti-cancer drug formulations

April 22, 2022
Medical Communications

Vivesto AB, an oncology-focused pharmaceutical company, has announced that it is advancing research into its proprietary drug delivery formulations, and …

News

Orasis Pharmaceuticals announces positive Phase III results of eye drop candidate

April 22, 2022
Medical Communications

Orasis Pharmaceuticals has announced that the Phase III NEAR-1 and NEAR-2 clinical trials, which evaluated the efficacy and safety of …

News

FDA approves Phase III Acute Respiratory Distress Syndrome (ARDS) Trial

April 22, 2022
Medical Communications

The FDA has approved Direct Biologics to proceed with its Phase III clinical trial into the treatment of Acute Respiratory …

News

WHO “strongly recommends” Paxlovid, calls for wide distribution from Pfizer

April 22, 2022
Medical Communications

WHO has endorsed the use of Pfizer’s oral antiviral treatment for high-risk patients with mild COVID-19, following an analysis of …

News

NIHR-supported trial reveals vaccine boosters maintain immunity three months on

April 21, 2022
Business Services

Latest results form the UK’s COV-BOOST study, led by University Hospital Southampton, have shown prolonged immune responses following third doses …

News

FDA’s Cancer Advisory Committee to evaluate safety of P13K inhibitors

April 21, 2022
Business Services

The FDA’s Oncologic Drugs Advisory Committee is holding a meeting today to discuss safety findings across the entire class of …

News

PacBio and Children’s Mercy Kansas City expand collaboration in rare disease

April 21, 2022
Business Services

PacBio has announced an expanded research collaboration with Children’s Mercy Kansas City, to use the multi-omics capabilities of PacBio’s Sequel …

News

New Programme to tackle health disparities and inequalities for women with heart failure

April 21, 2022
Business Services

Women diagnosed with heart failure have worse outcomes compared to men, in spite of a similar prevalence of the chronic …

News

Takeda Nuvaxovid COVID-19 vaccine approved in Japan

April 20, 2022
Research and Development

Takeda’s Nuvaxovid Intramuscular Injection (Nuvaxovid) has been approved by the Japan Mnistry of Health, Labour and Welfare (MHLW). This is …

News

Care to Collaborate: Cydar Medical announces partnership with Medtronic

April 20, 2022
Research and Development

Cydar Medical has announced a strategic collaboration with leading healthcare technology company Medtronic. Under the pilot arrangement, Cydar’s EV Maps …

News

Study initiated for first miniaturised robotic-assisted surgery platform

April 20, 2022
Research and Development

Virtual Incision Corporation has announced the FDA approval of an Investigational Device Exemption (IDE) supplement to complete the final stage …

News

NHS Health Chief calls for return of facemasks and social distancing

April 20, 2022
Research and Development

Chris Hopson, Chief Executive of NHS Providers, which represents trusts has urged ministers to discuss “sensible precautions” for the public, …

News

AstraZeneca drug granted FDA Priority Review

April 19, 2022
Manufacturing and Production

AstraZeneca and Daiichi Sankyo have announced that the lung cancer antibody drug conjugate, Enhertu, has received Priority Review from the …

News

FDA accept New Drug Application for GSK’s daprodustat

April 19, 2022
Manufacturing and Production

GSK has announced the FDA has accepted the New Drug Application (NDA) for daprodustat, an oral hypoxia-inducible factor prolyl hydroxylase …

News

VistaGen and AffaMed complete regulatory submissions for Phase III SAD trial

April 13, 2022
Research and Development

VistaGen and AffaMed have announced the completion of key regulatory preparations to initiate PALISADE global, a Phase III clinical trial …

News

NICE recommends avelumab for urothelial cancer patients

April 13, 2022
Research and Development

NICE has recommended avelumab as treatment for adults with locally advanced or metastatic urothelial cancer.The treatment, avelumab, will benefit over …

News

FDA and DEA warn online pharmacies illegally selling ADHD drug Adderall

April 13, 2022
Research and Development

The FDA and the US DEA have jointly issued warning letters to operators of two websites illegally selling Schedule II …

News

It could take up to six years to clear the patient backlog in Europe

April 13, 2022
Research and Development

Research has found that oncologists and surgeons across Europe estimate it will take at least three years to clear the …

News
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026